Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04488250 · ClinicalTrials.gov registry record · NA

Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana

A NA study of Stroke and HIV/AIDS, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
30
Enrollment target
2
Study locations

NCT04488250 is a NA study of Stroke and HIV/AIDS that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04488250, a NA study of Stroke and HIV/AIDS, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
2
Study locations

Study Summary

Today, nearly 37 million people are living with HIV (PLHIV) worldwide and 30 to 40% of them will have neurologic complications leading to disability. Our long-term working hypothesis is that an effective solution for increasing rehabilitation access in Botswana and improving functional outcomes of PLHIV having experienced a stroke with or without HIV uses an affordable robot and mobile health technologies to create a cost-effective intervention strategy. For this project, we test the feasibility of affordable robot therapy.

Conditions Studied

Interventions

  • OTHER Robot Therapy

Study Locations (2)

Pennsylvania

  • Penn Medicine Rittenhouse - Philadelphia

Other

  • University of Botswana - Gaborone

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-10-01
Est. Completion 2026-05
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04488250

The ClinicalTrials.gov registry entry for NCT04488250 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Robot Therapy is the first listed.

NCT04488250 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Other.

Frequently Asked Questions

What is clinical trial NCT04488250 about?

NCT04488250 is a clinical study titled "Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana". Today, nearly 37 million people are living with HIV (PLHIV) worldwide and 30 to 40% of them will have neurologic complications leading to disability. Our long-term working hypothesis is that an effective solution for increasing rehabilitation access in Botswana and improving functional outcomes of P...

What is the current status of trial NCT04488250?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-10-01. Estimated completion is 2026-05.

What conditions does trial NCT04488250 study?

This clinical trial studies the following conditions: Stroke, HIV/AIDS.

What interventions are being tested in trial NCT04488250?

The interventions under investigation include: Robot Therapy (OTHER).

Who is sponsoring clinical trial NCT04488250?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04488250 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.